Sandra Levy is Managing Editor-Projects. She covers self care, chains and business, home care, over-the-counter medicines and Rx-to-OTC switches. She joined <i>Drug Topics</i> in 1998.
Is phenylephrine an effective decongestant?April 2nd 2007
A group of researchers at the University of Florida College of Pharmacy recently submitted a citizen's petition asking the Food & Drug Administration to increase the maximum allowable dose of phenylephrine (PE) from 10 mg to 25 mg and to withdraw approval of phenylephrine for children under 12 years of age. The petition also called for additional research to validate the safety and effectiveness of the higher recommended dose.
R.Ph.s speak out about OTC version of orlistatMarch 5th 2007
Pharmacists appear pleased with the Food & Drug Administration's recent decision to allow orlistat 60-mg capsules to go over the counter (OTC) in the United States. (See Latebreakers, Feb. 19.) The OTC version, to be marketed by GlaxoSmithKline beginning this summer under the brand name alli, is for use by overweight adults 18 years and older in conjunction with a reduced-calorie, low-fat diet.
How will the minimum wage hike affect you?February 5th 2007
The House of Representatives recently passed a measure to increase the federal minimum wage to $7.25 an hour from its current rate of $5.15 an hour over a 26-month period. The Senate is expected to move swiftly to pass a similar measure. How will the hike affect chain and independent pharmacies?
New law requires OTC adverse event reportingFebruary 5th 2007
Congress just passed and President Bush signed the Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), also known as the Adverse Event Reports (AER) bill. The legislation will amend the federal Food, Drug & Cosmetic Act to require manufacturers to report "serious" adverse events for OTC drugs and dietary supplements to the Food & Drug Administration. The law becomes effective one year after its passage on Dec. 26.
NAMS issues new position statement on calciumJanuary 22nd 2007
Osteoporosis occurs most commonly in postmenopausal women, and the incidence increases with age. This concern has prompted the North American Menopause Society (NAMS) to issue a new evidence-based position statement on the role of calcium in peri- and postmenopausal women.
Physicians-to-be getting trained at Rite Aid storesJanuary 8th 2007
Picture this scenario: Family medicine residents complete a four-week rotation in a pharmacy, where they learn about the importance of collaborating with pharmacists to improve patient care. They also learn about over-the-counter medicines and how to write prescriptions.
Do loyalty programs boost drugstore sales?December 11th 2006
Drugstore customers who are rewards program members are more likely to have spent more money in the past six months than those not involved in a rewards program, according to a new on-line survey conducted by Maritz Research for Maritz Loyalty Marketing.
Will holiday sales be marvelous or middling?December 11th 2006
Rising gasoline prices have drained consumers' wallets this year. The housing market is losing steam. The war in Iraq is dragging on. Still, chains and independents are optimistic that consumers will fill Santa's sleigh with gifts plucked from their shelves. The National Retail Federation's (NRF) annual Holiday Consumer Intentions and Actions Survey offers plenty of reasons for retailers to celebrate.
PPSI to FDA: Regulate acetaminophen labelingNovember 20th 2006
Pharmacists Planning Service Inc. (PPSI) has submitted a citizen's petition to the Food & Drug Administration to regulate the labeling and packaging of acetaminophen/APAP-containing products so that the label states, "Contains acetaminophen. Do not take with any other acetaminophen/ APAP." PPSI is also asking that no more than 50 tablets be sold in a bottle and that the FDA mandate a MedGuide.
DEA issues rule on pseudoephedrine productsNovember 6th 2006
As the pharmacy community complies with the Drug Enforcement Administration's interim final rule on retail sales of pseudoephedrine-related products, pharmacy and retail associations are preparing to send their comments to the agency outlining their members' concerns.
Picture this: A patient who is taking the blood-thinning medication Coumadin (warfarin sodium, Bristol-Myers Squibb) visits his community pharmacy to have his blood checked. The pharmacist makes sure his dosage is correct and that his blood isn't getting too thin or too thick.
Nobody does it better: This annual feature salutes independent pharmacies and the many special services they provideOctober 9th 2006
Going the extra mile. Bending over backwards to serve. That's what sets some independent pharmacies apart. To learn who these standouts are, Drug Topics once again invited wholesalers across the United States to nominate their independent pharmacy customers that excel in four categories.